Friday, December 4, 2026 · 9:00 AM · Hyatt Centric Wall Street, NYC
The Peptide Symposium
Walk in on Friday with questions about peptides. Walk out knowing what you can prescribe, what you can say to a patient, what to charge, and how to keep it legal — so the next patient who asks is one you keep instead of refer.
Your Patients Are Already Asking. Most Practices Send Them Elsewhere.
Semaglutide. Tirzepatide. BPC-157. NAD+. Patients are walking into aesthetic and primary-care practices asking about compounds by name — and walking back out to a med spa down the road, because their own clinician has no answer for them.
That is the gap this room exists to close. Peptide therapy is the rare service line you can open for patients who are already in your chair, in a field where demand arrived faster than the training did.
Six speakers spend the day on the questions that actually stand between you and offering it: what is legal to prescribe today, what the evidence will support in front of a patient, where to source without risking your license, and how to position the service so the right patients ask for it.
This is not a hands-on injection course. It is six clinicians who prescribe peptides every week, laying out what is working and taking your questions — Friday, December 4, 2026, in person in Manhattan, the day after The Art of the Face Event. Free with the Member seat, or $399 on its own.
Empire faculty in session — the format the Symposium runs on: presentation, then the room.
Six Questions. Six People Who Can Answer Them.
These are the questions clinicians ask most about peptides. Each one has someone in the room whose job is to answer it.
“Is this a real service line, or a fad I’ll regret building around?”
Dr. Stephen Cosentino, DO
“Which peptides survived the 503A changes — and which can I no longer get?”
Dr. Joseph B. Beavers, MD
“Who is actually a candidate, and how do I document medical necessity?”
Dr. Valerie F. Civelli, MD
“A patient read about BPC-157 online. What can I honestly tell them?”
Dr. Chris Croley, MD
“How do the patients I want find out I offer this?”
Yurik Lozano, MBA
“What can I legally prescribe, advertise and charge for right now?”
Healthcare Law Counsel
Four Physicians. One Marketer. One Law Firm.
Four Empire faculty who prescribe and teach peptide medicine, Empire’s marketing director on branding and positioning, and healthcare counsel on the legal side. Tap any face to read their background.
The Part Nobody Says Out Loud
Someone Near You Already Offers Peptides.
Not a hospital system. A med spa with a nurse injector and a compounding account, taking the patient who asked you first. Peptide therapy did not wait for the profession to agree on it — it went where the demand was.
The clinicians who moved early are not smarter. They are just further along the same learning curve you would start on Friday.
Six Presentations. Six Open Discussions.
Each speaker presents, then joins the panel — so every topic gets a considered talk first and an open discussion after it, with the room asking questions.
01
Presentation
Decide Whether Peptides Are Your Next Five Years
Dr. Stephen Cosentino, DO
Twenty-eight years of watching clinicians rebuild their practices around something new. What peptide medicine makes possible for a physician who wants more control over how they practice — and why the clinicians who move early are the ones who set the standard for everyone else.
Then the floor opens — five colleagues and a room full of questions.
02
Presentation
Get Patients Asking for Peptides by Name
Yurik Lozano, MBA
How to name, position and present a peptide service so the right patients understand it and ask for it — and how to say it without overstepping what you can claim.
Then discussion: the clinical side pushes back on the commercial one.
03
Presentation
Prescribe GLP-1s Without Guessing
Dr. Joseph B. Beavers, MD
Where semaglutide and tirzepatide are taking aesthetic, weight-management and longevity practices — and what the phase 3 evidence does and does not support.
Then the panel takes it apart, and so does the room.
04
Presentation
Know Who to Treat — and How to Document Medical Necessity
Dr. Valerie F. Civelli, MD
Patient selection, consent and documentation in an aesthetic or regenerative setting, plus sourcing: 503A and 503B compounding, and vetting a pharmacy before you order.
Then open discussion — bring the case you are unsure about.
05
Presentation
Know What You Can Promise a Patient
Dr. Chris Croley, MD
What the evidence actually supports today, what remains investigational, and how to hold that line with a patient who has already read about it online.
Then the room tests it against the patients they are actually seeing.
06
Presentation
Run a Peptide Practice That Holds Up
Healthcare Law Counsel
Shifting FDA positions, corporate practice of medicine, medical-director duties and malpractice coverage — what a prescriber needs settled before the first patient.
Then the last discussion of the day, with everything on the table.
Every topic above is confirmed. Running times are published closer to the date.
Success Stories
Clinicians who trained with Empire
4.9★ Average Rating · 200,000+ Graduates · 300+ Verified Reviews
Physicians, nurses and PAs on what changed in their practice — and their revenue — after training with us.
A Nurse’s Journey from Challenges to Triumph
Maritza Mejia
From Urology to Aesthetics: Artistic Evolution
Dr. Lanna Cheuk
Partnering for Success: The Dynamic Journey of a Power Couple
Eric and Sunshine De La Cruz
Empowering Success: The Inspiring Journey of a Physician Assistant
Rupert Evans
Pioneering the Path from Doctor to Founder, CEO, CCO & Practice Owner
Sarah L. Allen, MD
Journey from Practitioners to Practice Owners
Chris Croley & Jerry Dwain
Remarkable Journey from Student to Key Opinion Leader
Dr. TJ Tsay
The Honest Question
Are Peptides Going Away? No.
GLP-1s carry phase 3 data in tens of thousands of patients and now sit in cardiovascular and obesity guidelines. The FDA’s compounding lists have moved twice in three years — that is a field being formalized, not one fading out.
Empire’s formulary runs to 128 named agents. That is not a trend list. It is a working pharmacopoeia, and it is still growing.
1.8 Million Searches a Month. None of Them Yours Yet.
In the United States alone, the five biggest peptide terms — tirzepatide, semaglutide, peptides, BPC-157 and sermorelin — are searched roughly 1.87 million times every month. This is not an emerging interest. It is one of the largest live conversations in medicine.
823,000“tirzepatide” · monthly US searches
368,000“semaglutide” · monthly US searches
201,000“BPC-157” · monthly US searches
~42,000“near me” peptide searches monthly
That last number is the one that should hold your attention. Roughly 42,000 times a month, someone in the United States searches for peptide therapy, semaglutide, tirzepatide or a peptide clinic near me. They are not researching. They are looking for a provider who is open.
And the market has already priced them. Advertisers pay up to $19.72 a click for “semaglutide near me” — per click, not per patient. That is what practices already offering this are willing to spend to reach the person who would have walked into your office.
semaglutide near me
tirzepatide near me
weight loss injections near me
hormone therapy near me
peptide clinic near me
peptide doctor near me
where to buy peptides
glp 1 near me
Search volumes and cost-per-click: Semrush, US database, August 2026.
$399 a Seat. Free If You Are a Member.
Seating is capped at 200. There are two ways in.
All six presentations and every panel discussion
Open Q&A with all six speakers
Seats are transferable — send a colleague or staff member if your schedule turns
Empire Members
Included free
The Symposium comes with the $499 Member seat for The Art of the Face Event — Empire’s thank-you to active Members. Any active Member as of the event date qualifies, and you can join before you RSVP.
Open to any licensed healthcare professional, whether or not you are coming to the evening event or hold an Empire membership. Same day, same six speakers.
Hyatt Centric Wall Street, Lower Manhattan — the same hotel hosting The Art of the Face Event the evening before, so one trip covers both. Rooms are available at a preferred attendee rate — see hotel & travel.
Before You Book
Does the Symposium carry CME credit?
No. The Symposium is an expert panel, not an accredited course — there is no CME attached to it. If you want accredited peptide training, that is the Peptide Therapy Certification, which carries 40 AMA PRA Category 1 Credits™.
What time does it start and finish?
Doors from 9:00 AM on Friday, December 4, 2026, at the Hyatt Centric Wall Street. The full running order with session times is published closer to the date.
Do I have to attend The Art of the Face Event as well?
No. The evening event is Thursday, December 3 and is a separate ticket. Book the Symposium on its own for $399, or claim it free with the $499 Member seat if you are attending both.
Is this hands-on?
No. There are no injections and no live demonstrations. This is presentations and moderated discussion, with clinicians who already prescribe peptides answering what works and what does not.
I am not an Empire Member. Can I still come?
Yes. The $399 seat is open to any licensed healthcare professional. If you would rather join first, membership makes the Symposium free with the Member event seat.
How many seats are there?
200. The Symposium runs in one room at the Hyatt Centric Wall Street, and the capacity is the room’s — there is no overflow and no livestream. Members claiming their free seat count toward the same 200.
Can I send a member of my staff instead?
Yes — seats are transferable. Email [email protected] with the name change before the event.
After Friday
The Empire Peptide Therapy Certification
A day of answers is a start. This is the training that turns peptides into something you actually offer — and a credential that says so.
Every question the panel raises on Friday — who to treat, what to source, what to charge, what is legal — taught properly, assessed, and credentialed. It includes the business and marketing training and the healthcare-law education, because a peptide practice needs all three to survive.
The Symposium carries no CME. The certification carries 40.
Founder, President & Medical Director, Empire Medical Training
Dr. Stephen Cosentino, DO
Board-Certified, Family Medicine
Founder of Empire Medical Training, 1998
22+ Years in Aesthetic Medicine
Dr. Cosentino founded Empire Medical Training in 1998 and still keeps daily, hands-on oversight of what it teaches. He earned his Doctor of Osteopathic Medicine at Nova Southeastern University and completed his Family Practice residency at Mt. Sinai in New York.
Every Empire credential carries his standard, and this one is no exception: he signs off on what the program claims, what it assesses, and what a graduate is entitled to say they can do.
Dr. Beavers is the creator of Empire's multi-part peptide video curriculum — the detailed, module-by-module foundation that anchors the PPC certification program. He earned his medical degree at Ross University School of Medicine and completed his Family Medicine residency at the Mayo Clinic in Rochester, Minnesota.
Before medicine, he trained at the United States Air Force Academy and the University of Florida, where he earned both a BS and an MS in Applied Physiology — a background that still shapes how he teaches peptide science: physiology first, protocols second. He brings more than 20 years of clinical experience to the program.
Dr. Civelli is double board-certified — in Family Medicine through the American Board of Family Medicine, and in Functional & Regenerative Medicine through ABAARM. She earned her MD at Windsor University School of Medicine and completed her Family Medicine residency at UCLA-affiliated Rio Bravo, where she served as Chief Resident.
Her research on chronic disease and innovative therapies has been published in peer-reviewed journals including Oxford University Press and the Journal of Investigative Medicine. She has served on multiple executive health and community boards, and her honors include being twice named "Outstanding Physician of the Year" and receiving the Hans Einstein Award. A physician, educator, and researcher, she bridges conventional medical rigor and innovation — with a mission to educate and empower clinicians through personalized, scientifically sound care.
Chief Medical Officer, Empire Medical Training
Dr. Chris Croley, MD
Board-Certified, Anesthesiology
Board-Certified, Critical Care Medicine
20+ Years of Clinical Experience
As Chief Medical Officer of Empire Medical Training, Dr. Croley oversees the medical standards behind every Empire program — including this certification. He is board-certified in Anesthesiology and Critical Care Medicine, trained at Rush and Northwestern, with more than 20 years of clinical experience.
His role in the certification program is the standard itself: ensuring the curriculum, assessments, and clinical protocols meet the bar Empire has held its training to since 1998.
Yurik Lozano is Empire’s Director of Marketing and a national marketing instructor for healthcare practitioners, teaching brand strategy, paid media and AI-driven marketing systems to clinicians building their own practices.
He leads marketing for Empire Medical Training and the American Academy of Procedural Medicine, and brings the commercial side of it: how a new service is named, positioned and made legible to the patients you actually want.
Empire is engaging a board-certified healthcare law firm to present the legal and regulatory session. The firm and presenting attorney are announced ahead of the event.
Friday, December 4 · 200 Seats
Stop Sending Peptide Patients Somewhere Else.
The next patient who asks you about semaglutide, BPC-157 or peptide therapy is coming either way. The only thing you control is whether you have an answer, a protocol and a price — or a referral to the practice down the road.
